As a woman-founded and led company with in-house manufacturing capabilities of its internally conceived portfolio of products, Femasys is well-positioned to deliver its solutions to the market with the achievement of global regulatory approvals.
James H. Liu, MD
Chief Medical Officer
Dr. James Liu has over 45 years of leadership experience in obstetric and gynecologic clinical practice, including clinical study execution while serving as the Chairman, Department of Obstetrics and Gynecology at University Hospital Health System, the Chair, Department of Reproductive Biology at Case Western Reserve University, and the Division Head, Reproductive Endocrinology and Infertility at the University of Cincinnati. Dr. Liu has authored over 130 publications and held numerous chair appointments for the American College of Obstetrics and Gynecology, and for seven years served on the practice committee for the American Society for Reproductive Medicine. He also has several issued patents, reviewed National Institutes of Health grants, served on the FDA Advisory Committee, and has participated as a principal investigator on numerous clinical pharmaceutical and medical device trials. Dr. Liu holds a BS Summa Cum Laude from Ohio State University and a MD from the Ohio State University School of Medicine.
